As of 2024-12-12, the Relative Valuation of Seelos Therapeutics Inc (SEEL) is 841.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.28 USD, the upside of Seelos Therapeutics Inc based on Relative Valuation is 65628.5%.
The range of the Relative Valuation is 710.76 - 911.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 25.2x | 23.1x |
| Forward P/E multiples | 22.4x - 26.1x | 25.1x |
| Fair Price | 710.76 - 911.84 | 841.32 |
| Upside | 55428.3% - 71137.6% | 65628.5% |
| Date | P/E |
| 2024-11-22 | 0.01 |
| 2024-11-21 | 0.01 |
| 2024-11-20 | 0.01 |
| 2024-11-19 | 0.01 |
| 2024-11-18 | 0.01 |
| 2024-11-15 | 0.02 |
| 2024-11-14 | 0.02 |
| 2024-11-13 | 0.02 |
| 2024-11-12 | 0.02 |
| 2024-11-11 | 0.02 |
| 2024-11-08 | 0.02 |
| 2024-11-07 | 0.02 |
| 2024-11-06 | 0.02 |
| 2024-11-05 | 0.02 |
| 2024-11-04 | 0.03 |
| 2024-11-01 | 0.03 |
| 2024-10-31 | 0.03 |
| 2024-10-30 | 0.03 |
| 2024-10-29 | 0.03 |
| 2024-10-28 | 0.04 |
| 2024-10-25 | 0.03 |
| 2024-10-24 | 0.03 |
| 2024-10-23 | 0.03 |
| 2024-10-22 | 0.03 |
| 2024-10-21 | 0.03 |
| 2024-10-18 | 0.03 |
| 2024-10-17 | 0.03 |
| 2024-10-16 | 0.03 |
| 2024-10-15 | 0.04 |
| 2024-10-14 | 0.07 |
| 2024-10-11 | 0.07 |
| 2024-10-10 | 0.07 |
| 2024-10-09 | 0.08 |
| 2024-10-08 | 0.09 |
| 2024-10-07 | 0.09 |
| 2024-10-04 | 0.10 |
| 2024-10-03 | 0.09 |
| 2024-10-02 | 0.09 |
| 2024-10-01 | 0.09 |
| 2024-09-30 | 0.11 |
| 2024-09-27 | 0.11 |
| 2024-09-26 | 0.14 |
| 2024-09-25 | 0.16 |
| 2024-09-24 | 0.14 |
| 2024-09-23 | 0.09 |
| 2024-09-20 | 0.09 |
| 2024-09-19 | 0.09 |
| 2024-09-18 | 0.09 |
| 2024-09-17 | 0.10 |
| 2024-09-16 | 0.09 |